Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turella, P.
Right arrow Articles by Caccuri, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turella, P.
Right arrow Articles by Caccuri, A. M.
[Cancer Research 65, 3751-3761, May 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Proapoptotic Activity of New Glutathione S-Transferase Inhibitors

Paola Turella1, Claudia Cerella2, Giuseppe Filomeni2, Angela Bullo1, Francesca De Maria1, Lina Ghibelli2, Maria Rosa Ciriolo2, Maurizio Cianfriglia3, Maurizio Mattei2, Giorgio Federici4, Giorgio Ricci1 and Anna Maria Caccuri1

Departments of 1 Chemical Sciences and Technologies and 2 Biology, University of Rome "Tor Vergata"; 3 Department of Drug Research and Evaluation, Section of Pharmacogenetics, Drug Resistance and Experimental Therapeutics, Istituto Superiore di Sanità; and 4 Children's Hospital IRCCS "Bambin Gesù," Rome, Italy

Requests for reprints: Anna Maria Caccuri, Department of Chemical Sciences and Technologies, University of Rome "Tor Vergata", Viale della Ricerca Scientifica, 00133-Rome, Italy. Phone: 39-06-72594378; Fax: 39-06-72594328; E-mail: caccuri{at}uniroma2.it.

Selected 7-nitro-2,1,3-benzoxadiazole derivatives have been recently found very efficient inhibitors of glutathione S-transferase (GST) P1-1,5 an enzyme which displays antiapoptotic activity and is also involved in the cellular resistance to anticancer drugs. These new inhibitors are not tripeptide glutathione-peptidomimetic molecules and display lipophylic properties suitable for crossing the plasma membrane. In the present work, we show the strong cytotoxic activity of these compounds in the following four different cell lines: K562 (human myeloid leukemia), HepG2 (human hepatic carcinoma), CCRF-CEM (human T-lymphoblastic leukemia), and GLC-4 (human small cell lung carcinoma). The LC50 values are in the micromolar/submicromolar range and are close to the IC50 values obtained with GSTP1-1, suggesting that the target of these molecules inside the cell is indeed this enzyme. The cytotoxic mechanism of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, the most effective GSTP1-1 inhibitor, has been carefully investigated in leukemic CCRF-CEM and K562 cell lines. Western blot and immunoprecipitation analyzes have shown that 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol promotes in both cell lines the dissociation of the GSTP1-1 in a complex with c-jun NH2-terminal kinase (JNK). This process triggers a reactive oxygen species (ROS)–independent activation of the JNK-mediated pathway that results in a typical process of apoptosis. Besides this main pathway, in K562 cells, a ROS-mediated apoptosis partially occurs (about 30%) which involves the p38MAPK signal transduction pathway. The low concentration of this new compound needed to trigger cytotoxic effects on tumor cells and the low toxicity on mice indicate that the new 7-nitro-2,1,3-benzoxadiazole derivatives are promising anticancer agents.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
G. Filomeni, P. Turella, M. L. Dupuis, O. Forini, M. R. Ciriolo, M. Cianfriglia, S. Pezzola, G. Federici, and A. M. Caccuri
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer
Mol. Cancer Ther., February 1, 2008; 7(2): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. L. Holley, A. A. Fryer, J. W. Haycock, S. E.W. Grubb, R. C. Strange, and P. R. Hoban
Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis
Carcinogenesis, November 1, 2007; 28(11): 2268 - 2273.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Huang, L. Mills, and L. L. Worth
Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells
Mol. Cancer Ther., May 1, 2007; 6(5): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Stella, V. Pallottini, S. Moreno, S. Leoni, F. De Maria, P. Turella, G. Federici, R. Fabrini, K. F. Dawood, M. L. Bello, et al.
Electrostatic Association of Glutathione Transferase to the Nuclear Membrane: EVIDENCE OF AN ENZYME DEFENSE BARRIER AT THE NUCLEAR ENVELOPE
J. Biol. Chem., March 2, 2007; 282(9): 6372 - 6379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Turella, G. Filomeni, M. L. Dupuis, M. R. Ciriolo, A. Molinari, F. De Maria, M. Tombesi, M. Cianfriglia, G. Federici, G. Ricci, et al.
A Strong Glutathione S-Transferase Inhibitor Overcomes the P-glycoprotein-mediated Resistance in Tumor Cells: 6-(7-NITRO-2,1,3-BENZOXADIAZOL-4-YLTHIO)HEXANOL (NBDHEX) TRIGGERS A CASPASE-DEPENDENT APOPTOSIS IN MDR1-EXPRESSING LEUKEMIA CELLS
J. Biol. Chem., August 18, 2006; 281(33): 23725 - 23732.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Ricci, F. De Maria, G. Antonini, P. Turella, A. Bullo, L. Stella, G. Filomeni, G. Federici, and A. M. Caccuri
7-Nitro-2,1,3-benzoxadiazole Derivatives, a New Class of Suicide Inhibitors for Glutathione S-Transferases: MECHANISM OF ACTION OF POTENTIAL ANTICANCER DRUGS
J. Biol. Chem., July 15, 2005; 280(28): 26397 - 26405.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.